1. Home
  2. PMCB vs OMH Comparison

PMCB vs OMH Comparison

Compare PMCB & OMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PharmaCyte  Biotech Inc.

PMCB

PharmaCyte Biotech Inc.

HOLD

Current Price

$0.42

Market Cap

4.0M

Sector

Health Care

ML Signal

HOLD

Logo Ohmyhome Limited

OMH

Ohmyhome Limited

SELL

Current Price

$8.00

Market Cap

4.6M

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
PMCB
OMH
Founded
1996
2015
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Real Estate
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
4.0M
4.6M
IPO Year
2001
2022

Fundamental Metrics

Financial Performance
Metric
PMCB
OMH
Price
$0.42
$8.00
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
97.6K
★ 6.6M
Earning Date
12-17-2026
09-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$39.14
Revenue Next Year
N/A
$145.74
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.30
$0.06
52 Week High
$1.51
$94.60

Technical Indicators

Market Signals
Indicator
PMCB
OMH
Relative Strength Index (RSI) 61.27 52.12
Support Level $0.32 $1.00
Resistance Level $0.77 N/A
Average True Range (ATR) 0.06 14.34
MACD 0.01 1.12
Stochastic Oscillator 91.64 6.70

Price Performance

Historical Comparison
PMCB
OMH

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a biotechnology company focused on developing cellular therapies for cancer based on its proprietary cellulose-based live cell encapsulation technology, Cell-in-a-Box. The technology is intended to be used as a platform for therapies for several types of cancer, including locally advanced, inoperable pancreatic cancer (LAPC). The current generation of the Company's product candidate is CypCaps. The Company is preparing to commercialize cellular therapies for cancer and advance clinical research and development, including a clinical trial in LAPC using encapsulated live cells. Its candidate therapy involves encapsulating genetically engineered human cells that convert an inactive chemotherapy drug into its active, cancer-killing form.

About OMH Ohmyhome Limited

Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, Digital Marketing Services, and emerging and other services. The firm operates in two segments, which are Brokerage, emerging and another related service; and Estate management services and other related services in Singapore.

Share on Social Networks: